Cooper Companies | Rövid Lejáratú Kötelezettségek



Current Liabilities változás Dátum
Abbott USD 13B 1.15B 2025-03
Align Technology USD 1.99B 47.08M 2025-03
AtriCure USD 61.22M 12.2M 2025-03
Avanos Medical USD 165.9M 47M 2024-12
Bausch Health Companies USD 4.26B 2.5B 2025-03
Baxter International USD 6.51B 311M 2024-12
Bayer EUR 28.95B 3.9B 2024-12
Becton, Dickinson and Co. USD 7.69B 27M 2025-03
Boston Scientific USD 6.4B 489M 2024-12
Cooper Companies USD 999.6M 23.2M 2025-01
Dentsply International USD 1.59B 47M 2024-12
Dexcom USD 3.04B 105.1M 2025-03
Edwards Lifesciences USD 1.51B 438.9M 2024-12
Globus Medical USD 855.91M 37.85M 2024-12
Haemonetics USD 253.23M 20.71M 2024-12
Hologic USD 989.7M 12.7M 2025-03
Insulet USD 528.4M 22.2M 2024-12
Integra LifeSciences USD 922.13M 9.56M 2024-12
Intuitive Surgical USD 2.01B 200.9M 2025-03
J&J USD 56.9B 6.58B 2025-03
Medtronic USD 11.84B 355M 2025-01
Merit Medical Systems USD 196.82M 19.58M 2025-03
Novartis USD 28.69B 560M 2024-12
ResMed USD 940.52M 88.56M 2025-03
STAAR Surgical USD 70.31M 3.96M 2024-12
Steris USD 891.12M 85.64M 2024-12
Stryker USD 7.93B 313M 2025-03
Tandem Diabetes Care USD 288.18M 41.13M 2025-03
Teleflex USD 675.91M 26.55M 2025-03
Zimmer Biomet Holdings USD 2.45B 1.12B 2024-12



Cooper Companies Rövid Lejáratú Kötelezettségek - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - May 2025.